Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types.
The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV types. However, limitations of these consensus primers are evident, particularly in regard to the variability in detection sensitivity among different HPV types. This study compared MY09/11 PCR with type-specific PCRs in the detection of oncogenic HPV types. The study population comprised 15, 774 patients. Consensus PCR failed to detect 522 (10.9%) HPV infections indicated by type-specific PCRs. A significant correlation between failure of consensus PCR and HPV type was found. HPV types 51, 68 and 45 were missed most frequently. The clinical relevance of the HPV infections missed by MY09/11 PCR was reflected in the fraction of cases with cytological abnormalities and in follow-up, showing 104 (25.4%) CIN2+ cases. The MY09/11 false negativity could be the result of poor sensitivity, mismatch of MY09/11 primers or disruption of L1 target by HPV integration or DNA degradation. Furthermore, MY09/11 PCR lacked specificity for oncogenic HPVs. Diagnostic accuracy of the PCR systems, in terms of sensitivity (MY09/11 PCR: 87.9%; type-specific PCRs: 98.3%) and specificity (MY09/11 PCR: 38.7%; type-specific PCRs: 76.14%), and predictive values for histologically confirmed CIN2+, suggest that type-specific PCRs could be used in a clinical setting as a reliable screening tool.
Depuydt
C E
CE
Laboratory for Clinical Pathology (Labo Lokeren, campus RIATOL, AML-RIATOL group), Antwerp, Belgium.
Boulet
G A V
GA
Horvath
C A J
CA
Benoy
I H
IH
Vereecken
A J
AJ
Bogers
J J
JJ
D052685:Alphapapillomavirus / Q000235:genetics* / Q000302:isolation & purification*; D020137:Base Pair Mismatch; D016384:Consensus Sequence; D004279:DNA, Viral / Q000032:analysis* / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009858:Oncogenic Viruses / Q000235:genetics* / Q000302:isolation & purification; D016133:Polymerase Chain Reaction / Q000379:methods*; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013045:Species Specificity
D004279:DNA, Viral